Logo image
Clinicopathologic Features, Management, and Outcomes Of Pediatric CRTC1::TRIM11 and MED15::ATF1 Tumors With Spitzoid Morphology: A Case Series
Journal article   Open access   Peer reviewed

Clinicopathologic Features, Management, and Outcomes Of Pediatric CRTC1::TRIM11 and MED15::ATF1 Tumors With Spitzoid Morphology: A Case Series

Michael R. Sargen, Madeline H. Fitzhugh, Jennifer S. Ko, Allison G. Close, Sara C. Horton, Faizan Malik, Larissa V. Furtado, Armita Bahrami, Brittani K. N. Seynnaeve, Alberto S. Pappo, …
Pediatric blood & cancer, Vol.72(8), e31814
08/2025
DOI: 10.1002/pbc.31814
PMCID: PMC13389253
PMID: 40390195
url
https://doi.org/10.1002/pbc.31814View
Published (Version of record) Open Access

Abstract

Limited information is available on the clinicopathologic features and management of pediatric CRTC1::TRIM11 (CTRTs) and MED15::ATF1 ‐rearranged tumors (MARTs). In this series of pediatric CTRTs ( n  = 5) and MARTs ( n  = 2), all tumors exhibited spitzoid morphology and expressed melanocytic markers. Metastatic progression occurred in one CTRT and two MARTs: all three received immunotherapy, resulting in disease control in two patients and one death due to progressive disease. A fourth individual had lymph node micrometastasis that remained stable without progression. This case series highlights the potentially aggressive behavior of these tumors and suggests that immunotherapy may be an effective treatment option for advanced disease.
Immunotherapy <italic>CRTC1::TRIM11</italic> fusion <italic>MED15::ATF1</italic> fusion melanoma Spitz spitzoid

Details

Metrics

Logo image